Related references
Note: Only part of the references are listed.Influenza virus resistance to neuraminidase inhibitors
Melanie Samson et al.
ANTIVIRAL RESEARCH (2013)
Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses
Sehee Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Phylogenetic, molecular and drug-sensitivity analysis of HA and NA genes of human H3N2 influenza A viruses in Guangdong, China, 2007-2011
P. Huang et al.
EPIDEMIOLOGY AND INFECTION (2013)
Modeling the global transmission of antiviral-resistant influenza viruses
Dennis L. Chao
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
The Anti-influenza Virus Effect of Phellinus igniarius Extract
Sangmoo Lee et al.
JOURNAL OF MICROBIOLOGY (2013)
DBA/2 mouse as an animal model for anti-influenza drug efficacy evaluation
Jin Il Kim et al.
JOURNAL OF MICROBIOLOGY (2013)
Genetic Requirement for Hemagglutinin Glycosylation and Its Implications for Influenza A H1N1 Virus Evolution
Jin Il Kim et al.
JOURNAL OF VIROLOGY (2013)
Efficacy, Safety, and Pharmacokinetics of Intravenous Peramivir in Children with 2009 Pandemic H1N1 Influenza A Virus Infection
Norio Sugaya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice
E. Bart Tarbet et al.
ANTIVIRAL RESEARCH (2012)
Treatment of oseltamivir-resistant influenza A (H1N1) virus infections in mice with antiviral agents
Donald F. Smee et al.
ANTIVIRAL RESEARCH (2012)
Peramivir for the treatment of influenza
Avinash K. Shetty et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2012)
Susceptibility of human H3N2 influenza virus to oseltamivir in South Korea, 2009-2011
Sehee Park et al.
JOURNAL OF MICROBIOLOGY (2012)
Comparable Fitness and Transmissibility between Oseltamivir-Resistant Pandemic 2009 and Seasonal H1N1 Influenza Viruses with the H275Y Neuraminidase Mutation
Diana D. Y. Wong et al.
JOURNAL OF VIROLOGY (2012)
Effect of an Asparagine-to-Serine Mutation at Position 294 in Neuraminidase on the Pathogenicity of Highly Pathogenic H5N1 Influenza A Virus
Maki Kiso et al.
JOURNAL OF VIROLOGY (2011)
The DBA.2 Mouse Is Susceptible to Disease following Infection with a Broad, but Limited, Range of Influenza A and B Viruses
Natalie Pica et al.
JOURNAL OF VIROLOGY (2011)
Influenza Drug Resistance
Andres Pizzorno et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Role of Permissive Neuraminidase Mutations in Influenza A/Brisbane/59/2007-like (H1N1) Viruses
Yacine Abed et al.
PLOS PATHOGENS (2011)
Effects of the Combination of Favipiravir (T-705) and Oseltamivir on Influenza A Virus Infections in Mice
Donald F. Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays
Ha T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Combination of peramivir and rimantadine demonstrate synergistic antiviral effects in sub-lethal influenza A (H3N2) virus mouse model
Shanta Bantia et al.
ANTIVIRAL RESEARCH (2010)
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice
Donald F. Smee et al.
ANTIVIRAL RESEARCH (2010)
Effect of the Neuraminidase Mutation H274Y Conferring Resistance to Oseltamivir on the Replicative Capacity and Virulence of Old and Recent Human Influenza A(H1N1) Viruses
Mariana Baz et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Assessing the Viral Fitness of Oseltamivir-Resistant Influenza Viruses in Ferrets, Using a Competitive-Mixtures Model
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2010)
Oseltamivir-Resistant Variants of the 2009 Pandemic H1N1 Influenza A Virus Are Not Attenuated in the Guinea Pig and Ferret Transmission Models
Christopher W. Seibert et al.
JOURNAL OF VIROLOGY (2010)
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
PLOS ONE (2010)
T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
Maki Kiso et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Permissive Secondary Mutations Enable the Evolution of Influenza Oseltamivir Resistance
Jesse D. Bloom et al.
SCIENCE (2010)
Combination Chemotherapy for Influenza
Elena A. Govorkova et al.
VIRUSES-BASEL (2010)
Effect of Neuraminidase Inhibitor-Resistant Mutations on Pathogenicity of Clade 2.2 A/Turkey/15/06 (H5N1) Influenza Virus in Ferrets
Natalia A. Ilyushina et al.
PLOS PATHOGENS (2010)
Characterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
Maki Kiso et al.
PLOS PATHOGENS (2010)
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008
M. Jonges et al.
ANTIVIRAL RESEARCH (2009)
Intracellular metabolism of favipiravir (T-705) in uninfected and influenza A (H5N1) virus-infected cells
Donald F. Smee et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Mutations of neuraminidase implicated in neuraminidase inhibitors resistance
Olivier Ferraris et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Treatment of Late Stage Disease in a Model of Arenaviral Hemorrhagic Fever: T-705 Efficacy and Reduced Toxicity Suggests an Alternative to Ribavirin
Brian B. Gowen et al.
PLOS ONE (2008)
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)
Nadezhda E. Yun et al.
VIROLOGY (2008)
The war against influenza: discovery and development of sialidase inhibitors
Mark von Itzstein
NATURE REVIEWS DRUG DISCOVERY (2007)
Mechanism of action of T-705 against influenza virus
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Combination treatment of influenza A virus infections in cell culture and in mice with the cyclopentane neuraminidase inhibitor RWJ-270201 and ribavirin
DF Smee et al.
CHEMOTHERAPY (2002)
In vitro and in vivo activities of anti-influenza virus compound T-705
Y Furuta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
DF Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
RW Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
